Mailed feedback to primary care physicians on antibiotic prescribing Post date 5 June 2024 ← TDR at 50: advancing a longstanding commitment to inclusion → Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma